ARCHIVES

FDA Tightens Conflict of Interest Rules For Advisors.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

Tom Harkin Is New Chairman f Senate Labor-HS-Education Subcommittee

January 13, 1989

Contract Awards: Texas Group Receives $472,000 To Monitor Asbestos Workers

August 23, 1974

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011